Andere Kunden interessierten sich auch für
![Radiopharmaceuticals]( "Radiopharmaceuticals")
Radiopharmaceuticals137,99 €![Two-Dimensional Superconductivity in Rare Earth Oxybismuthides with Unusual Valent Bismuth Square Net]( "Two-Dimensional Superconductivity in Rare Earth Oxybismuthides with Unusual Valent Bismuth Square Net")
Two-Dimensional Superconductivity in Rare Earth Oxybismuthides with Unusual Valent Bismuth Square Net142,99 €![Synthesis of Molybdenum and Tungsten Oxo and Imido Alkylidene NHC Complexes and Their Use in Stereoselective Ring-Opening Metathesis Polymerization]( "Synthesis of Molybdenum and Tungsten Oxo and Imido Alkylidene NHC Complexes and Their Use in Stereoselective Ring-Opening Metathesis Polymerization")
Synthesis of Molybdenum and Tungsten Oxo and Imido Alkylidene NHC Complexes and Their Use in Stereoselective Ring-Opening Metathesis Polymerization95,88 €![The Study and Use of Covalent Bonds in Chemistry: New Insights and Old Knowledge]( "The Study and Use of Covalent Bonds in Chemistry: New Insights and Old Knowledge")
The Study and Use of Covalent Bonds in Chemistry: New Insights and Old Knowledge210,99 €![Exploring IoT Sensors and Their Applications]( "Exploring IoT Sensors and Their Applications")
Exploring IoT Sensors and Their Applications92,99 €![Soft Magnetic Materials and Their Application]( "Soft Magnetic Materials and Their Application")
Soft Magnetic Materials and Their Application93,99 €![Exploration and Development of Unconventional Oil and Gas Resources]( "Exploration and Development of Unconventional Oil and Gas Resources")
Exploration and Development of Unconventional Oil and Gas Resources96,99 €
The purpose of this Special Issue is to bring together research and review papers that use radiopharmaceuticals in drug development. Labeling a potential drug with a radionuclide for imaging and injecting radiopharmaceuticals into animals or humans can immediately provide information about the in vivo destiny of the compound through the application of PET or SPECT scanners. Radionuclides can be useful throughout the whole process of developing new drugs; in particular, if the results obtained are negative and the potential drug can be discarded early on in the process, considerable effort and money can be saved. An alternative way to obtain information about the in vivo destiny/effect of a potential drug is to imagine, for example, a target organ or a tumor with radiopharmaceuticals before and after treatment with a drug. Determining how a drug is metabolized is an integrated part of drug development. Labeling a drug with a radionuclide and providing it with a radioactive tag can help in subsequently determining its location and quantifying metabolites. If the metabolites can be extracted, the solutions can be examined through analytical measurements. Using ionizing radiation in the treatment of tumors is also an application for radiopharmaceuticals which is expected to expand greatly in the years to come. By labeling a specific compound with a radionuclide used for diagnostics we can establish whether it accumulates in the tumor. The same compound is thereafter combined with a radionuclide for treatment. This Special Issue contains seven original research papers, one communication, and two reviews.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.